(Q46926316)

English

Decreased in vivo oxidative stress and decreased platelet activation following metformin treatment in newly diagnosed type 2 diabetic subjects

scientific article published in March 2008

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/17966969

Decreased in vivo oxidative stress and decreased platelet activation following metformin treatment in newly diagnosed type 2 diabetic subjects (English)

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/17966969

1 reference

based on heuristic

inferred from title

author name string

Gloria Formoso

1

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/17966969

Elena A De Filippis

2

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/17966969

Noemi Michetti

3

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/17966969

Patrizia Di Fulvio

4

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/17966969

Assunta Pandolfi

5

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/17966969

Tonino Bucciarelli

6

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/17966969

Giovanni Ciabattoni

7

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/17966969

Antonio Nicolucci

8

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/17966969

Giovanni Davì

9

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/17966969

Agostino Consoli

10

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/17966969

publication date

1 March 2008

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/17966969

Diabetes - Metabolism: Research and Reviews

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/17966969

24

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/17966969

3

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/17966969

231-237

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/17966969

In vivo formation of 8-iso-prostaglandin f2alpha and platelet activation in diabetes mellitus: effects of improved metabolic control and vitamin E supplementation.

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.794

21 January 2018

Diabetes mellitus, hypercholesterolemia, and hypertension but not vascular disease per se are associated with persistent platelet activation in vivo. Evidence derived from the study of peripheral arterial disease.

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.794

21 January 2018

Thromboxane biosynthesis and platelet function in type II diabetes mellitus

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.794

21 January 2018

In vivo formation of 8-Epi-prostaglandin F2 alpha is increased in hypercholesterolemia.

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.794

21 January 2018

Radioimmunoassay of 11-dehydrothromboxane B2 in human plasma and urine.

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.794

21 January 2018

Diabetes mellitus, oxidative stress and advanced glycation endproducts

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.794

21 January 2018

Clinical relevance of the oxidative stress concept.

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.794

7 January 2021

based on heuristic

inferred from DOI database lookup

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.794

7 January 2021

based on heuristic

inferred from DOI database lookup

The mystery of diabetes and atherosclerosis: time for a new plot

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.794

7 January 2021

based on heuristic

inferred from DOI database lookup

Oxidative stress and stress-activated signaling pathways: a unifying hypothesis of type 2 diabetes

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.794

7 January 2021

based on heuristic

inferred from DOI database lookup

Antiplatelet agents in the prevention of diabetic vascular complications.

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.794

7 January 2021

based on heuristic

inferred from DOI database lookup

Glomerular actions of a free radical-generated novel prostaglandin, 8-epi-prostaglandin F2 alpha, in the rat. Evidence for interaction with thromboxane A2 receptors

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.794

7 January 2021

based on heuristic

inferred from DOI database lookup

The F2-isoprostane, 8-epi-prostaglandin F2 alpha, a potent agonist of the vascular thromboxane/endoperoxide receptor, is a platelet thromboxane/endoperoxide receptor antagonist

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.794

7 January 2021

based on heuristic

inferred from DOI database lookup

Oxidant stress, inflammation and atherogenesis

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.794

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.794

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of gliclazide versus metformin on the clinical profile and lipid peroxidation markers in type 2 diabetes

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.794

7 January 2021

based on heuristic

inferred from DOI database lookup

Monotherapy with metformin: does it improve hypoxia in type 2 diabetic patients?

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.794

7 January 2021

based on heuristic

inferred from DOI database lookup

Measurement of F(2)-isoprostanes as an index of oxidative stress in vivo

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.794

7 January 2021

based on heuristic

inferred from DOI database lookup

Assessing the predictive accuracy of QUICKI as a surrogate index for insulin sensitivity using a calibration model

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.794

7 January 2021

based on heuristic

inferred from DOI database lookup

Oxidative stress and the use of antioxidants in diabetes: linking basic science to clinical practice

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.794

7 January 2021

based on heuristic

inferred from DOI database lookup

An intracellular modulation of free radical production could contribute to the beneficial effects of metformin towards oxidative stress

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.794

7 January 2021

based on heuristic

inferred from DOI database lookup

An insulin sensitizer improves the free radical defense system potential and insulin sensitivity in high fructose-fed rats.

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.794

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of four-week metformin treatment on plasma and erythrocyte antioxidative defense enzymes in newly diagnosed obese patients with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.794

7 January 2021

based on heuristic

inferred from DOI database lookup

Metformin reduces endothelial cell expression of both the receptor for advanced glycation end products and lectin-like oxidized receptor 1

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.794

7 January 2021

based on heuristic

inferred from DOI database lookup

Metformin prevents glucose-induced protein kinase C-beta2 activation in human umbilical vein endothelial cells through an antioxidant mechanism

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.794

7 January 2021

based on heuristic

inferred from DOI database lookup

Antidiabetic and antimalarial biguanide drugs are metal-interactive antiproteolytic agents

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.794

7 January 2021

based on heuristic

inferred from DOI database lookup

Lipid peroxidation in diabetes mellitus

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.794

7 January 2021

based on heuristic

inferred from DOI database lookup

Isoprostane formation and inhibition in atherothrombosis

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.794

7 January 2021

based on heuristic

inferred from DOI database lookup

Increased production of platelet thromboxane B2 in non-insulin-dependent diabetes. Relationship to vascular complications

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.794

7 January 2021

based on heuristic

inferred from DOI database lookup

Platelets from patients with diabetes mellitus have impaired ability to mediate vasodilation

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.794

7 January 2021

based on heuristic

inferred from DOI database lookup

Metformin reduces platelet hypersensitivity in hypercholesterolemic rabbits

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.794

7 January 2021

based on heuristic

inferred from DOI database lookup

Study of the effect of metformin on platelet aggregation in insulin-dependent diabetics

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.794

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of metformin on insulin resistance, risk factors for cardiovascular disease, and plasminogen activator inhibitor in NIDDM subjects. A study of two ethnic groups.

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.794

7 January 2021

based on heuristic

inferred from DOI database lookup

Platelet activation in type 2 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.794

7 January 2021

based on heuristic

inferred from DOI database lookup

Lipid and protein oxidation contribute to a prothrombotic state in patients with type 2 diabetes mellitus.

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.794

7 January 2021

based on heuristic

inferred from DOI database lookup

Diabetes, oxidative stress, and antioxidants: a review

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.794

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of metformin on glutathione and magnesium in normal and streptozotocin-induced diabetic rats.

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.794

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/DMRR.794

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/17966969

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/17966969

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46926316&oldid=2138009308"